Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CEM Wins Peptide Patent Dispute with Biotage

Published: Friday, May 10, 2013
Last Updated: Friday, May 10, 2013
Bookmark and Share
The patent broadly covers the overall process of microwave peptide synthesis including the steps of deprotection and coupling.

The European Patent No. 1 491 552, covering microwave assisted solid phase peptide synthesis, has been upheld in an oral proceeding at the European Patent Office. The opposition proceeding had been initiated by Biotage in an attempt to revoke the patent. Biotage was unable to find or provide any new prior art that could be used to nullify the patent.

"We are very pleased with the outcome of the examination and with the result that the patent has been fully upheld," commented Michael J. Collins, PhD., president and CEO of CEM Corporation.  "This confirms the fact that the patent is valid and enforceable.  Microwave peptide synthesis, which was developed by CEM, has been shown to dramatically reduce cycle times and increase purity particularly for difficult sequences. It has become a major new enabling technology for the peptide community."

"Microwave peptide synthesis using the methods claimed in EP 1 491 552 can only be performed using CEM microwave systems which carry a license for this process," Collins continued.  "No other microwave systems (including Biotage) can be offered or used to perform CEM's patented microwave peptide synthesis (including deprotection and coupling) without being in violation of this or other related CEM patents. Obviously, we will continue to ensure that all of our intellectual property rights are fully enforced and protected.

"CEM has similar issued patents in the United States, Canada, and Japan. In addition to these process patents, we have a number of issued and pending hardware and chemistry patents related to this field. We also have a major on-going Research and Development effort aimed at expanding the knowledge base and creating next generation technology for peptide synthesis.   

"Our goal is to be the worldwide leader in providing unique and innovative solutions for doing peptide synthesis using our core microwave technology. We have a number of exciting new developments related to both hardware and chemistry innovation that will be coming to market in the next year," Collins concluded. 


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

CEM Launches Single Channel Microwave Peptide Synthesizer
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce the introduction of the new Liberty1™ Single Channel Microwave Peptide Synthesizer.
Tuesday, November 10, 2009
CEM Announces 2009 MJ Collins Award Winner
Amy Kallmerten, a graduate student at Northeastern University, has won the 2009 MJ Collins Award for outstanding research by a student in the field of microwave chemistry.
Tuesday, August 18, 2009
Microwave Peptide Synthesis Highlighted at European Peptide Symposium
The conference features research from some of the world’s leading chemists, who are increasingly turning to microwave peptide synthesis to drive their reactions.
Tuesday, September 30, 2008
CEM Microwave Systems Can be used for Approved USEPA Method 3546
Company’s licensed microwave extraction process for organic analytes has been officially recognized by the agency with the publication of Method 3546.
Monday, May 19, 2008
CEM Announces Finalists for the 2007 MJ Collins Award
The award recognizes outstanding research by a student in the field of microwave chemistry.
Wednesday, July 11, 2007
Expanded Applications in Bioscience and Open Vessel Reactions Highlight 5th International Microwaves in Chemistry Conference
The conference held in April at Imperial College in London highlighted research in bioscience applications and expanded use of microwave-assisted open vessel reactions.
Thursday, May 31, 2007
CEM’s Review Article on the use of Microwave Energy in Bioscience Applications Published
The article develops a theoretical basis for the unique effects that microwave energy has on biomolecules and interaction of proteins and biomolecules with microwaves.
Friday, April 13, 2007
CEM Corporation Sells 100th Automated Peptide Synthesizer
CEM has sold its 100th Liberty™ Microwave Peptide Synthesizer in only 2 years time, which was first launched in Feb. 2005.
Wednesday, March 07, 2007
CEM Announces the Opening of Microwave Chemistry Division in India
Objective of the division will be to further the introduction of microwave chemistry to a much wider segment of the Indian market.
Wednesday, November 01, 2006
CEM and USEPA Enter into R&D Agreement
Companies announce collaboration for research into green microwave chemistry scale-up methods.
Wednesday, September 27, 2006
Major Pharmaceutical Companies & Research Facilities Using Microwave Synthesis to Produce Difficult Peptides
The Liberty System from CEM is designed to provide significant benefits in speed, yield enhancements and product purity.
Monday, July 31, 2006
Pioneer in Microwave Chemistry to Speak at the International Microwaves in Chemistry Conference
Dr. Rajender S. Varma will be the Keynote Speaker for the 4th International Microwaves in Chemistry Conference.
Monday, February 20, 2006
CEM Announces new Microwave Chemistry Award
The M.J. Collins Award will recognize outstanding research by a student in the field of microwave chemistry.
Monday, February 13, 2006
Microwaves in Chemistry Conference Attracts Largest Number of International Attendees
This year’s conference features a record 23 speakers from industry and academia.
Monday, February 06, 2006
CEM Creates New Division for Chemical Synthesis Scale Up
The Chemical Synthesis Scale-up Division will be charged with developing systems to produce multi-kilogram to manufacturing scale quantities of synthesized materials.
Friday, September 23, 2005
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!